Cardiovascular diseases are the leading cause of mortality and morbidity in adults worldwide. Clinical presentations of acute coronary syndrome (ACS) vary with STEMI among the most urgent entities requiring timely coronary revascularization. CMR enables comprehensive assessment of cardiac structure, function, and myocardial tissue injury after reperfused STEMI. This study aimed to investigate the association of baseline serum levels of CCN1, NT-proBNP, hsTnT, and PCSK9 with CMR-derived infarct characteristics assessed 30 days after acute STEMI in the intermediate post-infarction stage.

Read full article (IJC Heart & Vasculature 64 (2026) 101918) here!